A small molecule compound was recently found to reduce PGC-1α-dependent gluconeogenic activity in the liver by increasing PGC-1α acetylation, leading to an amelioration of glucose homeostasis in a murine model of diabetes (77). Here, PPARGC1A is linked to diabetes mellitus.